Clinical data
AHFS/ International Drug Names
ATC code P01AB06 (WHO) QP51AA06 (WHO)
CAS Number 6506-37-2
PubChem (CID) 23009
ChemSpider 21533
KEGG D07352 YesY
ECHA InfoCard 100.026.723
Chemical and physical data
Formula C9H14N4O3
Molar mass 226.23 g/mol
3D model (Jmol) Interactive image

Nimorazole (INN) is a nitroimidazole anti-infective.[1] It is also being investigated for the treatment of head and neck cancer.[2][3]


  1. Roy, R. B.; Laird, S. M.; Heasman, L. (1975). "Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole". The British Journal of Venereal Diseases. 51 (4): 281–284. PMC 1046566Freely accessible. PMID 1098732.
  2. Henk, J. M.; Bishop, K.; Shepherd, S. F. (2003). "Treatment of head and neck cancer with CHART and nimorazole: Phase II study". Radiotherapy and Oncology. 66 (1): 65–70. doi:10.1016/S0167-8140(02)00284-0. PMID 12559522.
  3. Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at
This article is issued from Wikipedia - version of the 7/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.